Chemistry:Vepalimomab
From HandWiki
Short description: Monoclonal antibody
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | VAP-1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
Vepalimomab is an experimental mouse monoclonal antibody intended for the treatment of inflammations. It blocks vascular adhesion protein 1.[1] Development of the drug was discontinued in 2002.[2]
References
- ↑ "Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis". Basic & Clinical Pharmacology & Toxicology 96 (6): 429–35. June 2005. doi:10.1111/j.1742-7843.2005.pto_05.x. PMID 15910406.
- ↑ "Vepalimomab". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800016990.
 |  |
